Oxagen

Apini Therapeutics

This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.

Lead Biologics

The company develops antibody-based immunotherapies for cancer and autoimmune diseases, targeting pharmaceutical firms and research institutions for early-stage development and collaboration.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.

STipe Therapeutics

The company develops drugs targeting protein-protein interactions within the STING pathway to treat cancer and autoimmune diseases for healthcare institutions and pharmaceutical firms.

Redx Pharma

This clinical-stage biotechnology company develops small molecule medicines for fibrotic diseases and oncology for pharmaceutical partners and patients with unmet medical needs.

Peroxitech

This biopharmaceutical company develops peptide-based therapeutics to treat acute lung injury and other oxidative injury diseases for patients and healthcare providers.

EXO Therapeutics

This biotechnology company develops small-molecule drugs targeting enzyme exosites for healthcare institutions and pharmaceutical partners to treat oncology and inflammatory diseases.

Origo Biopharma

This clinical-stage biotechnology company develops small molecule therapies targeting the transforming growth factor beta pathway to treat fibrosis and cancer in healthcare patients.